Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-26

Clinical Trial Update: Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial comparing BRIDIN-plus with Combigan for efficacy and ocular surface in patients with glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIDIN-plus
  • Combigan (brimonidine tartrate and timolol maleate)

Snippet

Sponsor: CHA University | Conditions: Glaucoma, Ocular Hypertensive | Phase 4 | Status: COMPLETED